Latest News

Read the latest news and updates from Oncologica

Mutation-Targeted Therapy Slows Lung Cancer (NSCLC)

Patients with previously treated advanced non-small cell lung cancer (NSCLC) lived more than twice as long without disease progression when treated with a drug that targets a key resistance mutation versus standard chemotherapy, investigators reported. Treatment...